The Jastreboff Phase 2 trial randomised 338 adults with body mass index 30 (or 27 with at least one weight-related condition) to retatrutide 1, 4, 8, or 12 mg subcutaneously once weekly, or placebo, for 48 weeks
No human trial established reversal of frailty, disease risk, organ ageing or mortality
This ingredient mixes easily into existing formulations and quickly elevates your performance levels
This simple finger-prick blood test measures your Glutathione Index, giving you insight into one of the bodys most important protective systems and whether your levels are in the optimal range for healthy brain ageing
For a deeper dive into the molecule itself, explore What Is in Glutathione
In my view, launching a copper peptide serum should be approached as a strategic investment rather than a quick response to a market trend